Details of the Drug Combinations

General Information of This Drug (ID: DMHS29U)

Drug Name
Iboctadekin   DMHS29U
Indication
Disease Entry ICD 11 Status REF
Non-hodgkin lymphoma 2B33.5 Phase 1 [1]
Ovarian cancer 2C73 Phase 1 [1]

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Iboctadekin + FOZIVUDINE TIDOXIL DCD84SY FOZIVUDINE TIDOXIL Ovarian cancer [2]
Rituximab + Iboctadekin DC38HON Rituximab Follicular lymphoma; Non-hodgkin lymphoma; Atrial fibrillation [3]
------------------------------------------------------------------------------------

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008435)
2 Clinical pipeline report, company report or official report of GlaxoSmithKline.
3 FDA Drug Development and Drug Interactions